Acute coronary syndrome biomarkers: The need for more adequate reporting

Circulation

Volumn 110, Issue 2, 2004, Pages 104-106

  Jaffe, Allan S ^a   Katus, Hugo ^b  

^a MAYO CLINIC   (United States)

^b UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

Coronary disease; Editorials; Troponin

Indexed keywords

BIOCHEMICAL MARKER; CREATINE KINASE MB; TROPONIN I;

ACCURACY; ATHEROSCLEROSIS; BIOASSAY; COEFFICIENT OF VARIATION; CORONARY ARTERY DISEASE; CUT OFF VALUE; EDITORIAL; HEART MUSCLE ISCHEMIA; HUMAN; INFORMATION PROCESSING; PERFORMANCE; PRIORITY JOURNAL; PROCESS OPTIMIZATION; PROGNOSIS; RECEIVER OPERATING CHARACTERISTIC; REFERENCE VALUE; RISK; SAMPLING; STATISTICAL PARAMETERS;

BIOLOGICAL MARKERS; CORONARY DISEASE; CREATINE KINASE; CREATINE KINASE, MB FORM; HUMANS; ISOENZYMES; RESEARCH DESIGN; ROC CURVE; SENSITIVITY AND SPECIFICITY; SPECIMEN HANDLING; TROPONIN T;

EID: 3142760089     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.0000135581.79161.35     Document Type: Editorial

References (21)

1. Alpert JS, Thygesen K, Antman E, et al. Myocardial infarction redefined: a consensus document of The Joint European Society of Cardiology/Am College of Cardiology Committee for the redefinition of myocardial infarction. J Am Coll Cardiol. 2000;36:959-969.
2. Hamm CW, Ravkilde J, Gerhardt W, et al. The prognostic value of serum troponin T in unstable angina. N Engl J Med. 1992;327:146-150.
3. Ottani F, Galvani M, Nicolini FA, et al. Elevated cardiac troponin levels predict the risk of adverse outcome in patients with acute coronary syndromes. Am Heart J. 2000;140:917-927.
4. Hamm CW. Cardiac biomarkers for rapid evaluation of chest pain. Circulation. 2001;104:1454-1456.
5. Antman EM, Tanasijevic MJ, Thompson B, et al. Cardiac-specific troponin I levels to predict the risk of mortality in patients with acute coronary syndromes. N Engl J Med. 1996;335:1342-1349.
6. Aviles RJ, Askari AT, Lindahl B, et al. Troponin T levels in patients with acute coronary syndromes, with or without renal dysfunction. N Engl J Med. 2002;346:2047-2052.
7. Morrow DA, Cannon CP, Rifai N, et al. Ability of minor elevations of troponins I and T to predict benefit from an early invasive strategy in patients with unstable angina and non-ST elevation myocardial infarction: results from a randomized trial. JAMA. 2001;286:2405-2412.
8. James S, Armstrong P, Califf R, et al. Troponin T levels and risk of 30-day outcomes in patients with the acute coronary syndrome: prospective verification in the GUSTO-IV trial. Am J Med. 2003;115: 178-184.
9. Brennan M, Penn MS, Van Lente F, et al. Prognostic value of myeloperoxidase in patients with chest pain. N Engl J Med. 2003;349:1595-1604.
10. Heeschen C, Dimmeler S, Hamm CW, et al. Soluble CD40 ligand in acute coronary syndromes. N Engl J Med. 2003;348:1104-1111.
11. Newby LK, Storrow AB, Gibler WB, et al. Bedside multimarker testing for risk stratification in chest pain units: the chest pain evaluation by creatine kinase-MB, myoglobin, and troponin I (CHECKMATE) study. Circulation. 2001;103:1832-1837.
12. Panteghini M, Pagani F, Yeo KTJ, et al. Evaluation of the imprecision at low-range concentrations of the assays for cardiac troponin determination. Clin Chem. 2004;50:327-330.
13. Jaffe A. Caveat emptor. Am J Med. 2003;115:241-244.
14. McCord J, Nowak RM, McCullough PA, et al. Ninety-minute exclusion of acute myocardial infarction by use of quantitative point-of-care testing of myoglobin and troponin I. Circulation. 2001;104:1483-1488.
15. de Lemos JA, Morrow MA, Sabatine MS, et al. Association between plasma levels of monocyte chemoattractant protein-I and long-term clinical outcomes in patients with acute coronary syndromes. Circulation. 2003;107:690-695.
16. Kwong RY, Schussheim AE, Rekhraj S, et al. Detecting acute coronary syndrome in the emergency department with cardiac magnetic resonance imaging. Circulation. 2003;107:531-537.
17. Baldus S, Heeschen C, Meinertz T, et al. Myeloperoxidase serum levels predict risk in patients with acute coronary syndromes. Circulation. 2003;108:1440-1445.
18. Heeschen C, Dimmeler S, Fichtlscherer S, et al. Prognostic value of placental growth factor in patients with acute chest pain. JAMA. 2004; 291:435-441.
19. Bodor GS, Porter S, Landt Y, et al. Development of monoclonal antibodies for an assay of cardiac troponin-I and preliminary results in suspected cases of myocardial infarction. Clin Chem. 38:2203-2214.
20. Muller-Bardorf M, Hallermayer K, Schroder A, et al. Improved troponin T ELISA specific for cardiac troponin T isoform: assay development and analytical and clinical validation. Clin Chem. 1997;43:458-466.
21. Eisenberg PR, Jaffe AS, Stump DC, et al. Validity of enzyme-linked immunosorbent assays of cross-linked fibrin degradation products as a measure of clot lysis. Circulation. 1990;84:1159-1168.